Latest News
Femtogenix Presents Novel Data on Antibody Drug Conjugates Containing Reduced Potency Payloads in Solid Tumour Models
Femtogenix presents efficacy and toxicity data on antibody drug conjugates containing new generation of DNA-binding therapeutic payloads
Iksuda Therapeutics and Femtogenix Sign License Agreement
Femtogenix Presents Data at AACR Annual Meeting 2018 Showing High Potency of Its New Generation DNA-Binding Payloads in Antibody Drug Conjugates
Femtogenix to present a plenary session entitled “Pyridinobenzodiazepines: A Novel Class of ADC Payloads” at World ADC San Diego 2017